The M(r) 193,000 vault protein is up-regulated in multidrug-resistant cancer cell lines

Cancer Research

Volumn 60, Issue 4, 2000, Pages 1104-1110

  Schroeijers, Anouk B ^a   Siva, Amara C ^b   Scheffer, George L ^a   De Jong, Mariska C ^a   Bolick, Sophie C E ^a   Dukers, Danny F ^a   Slootstra, Jerry W ^c   Meloen, Rob H ^c   Wiemer, Erik ^d   Kickhoefer, Valerie A ^b   Rome, Leonard H ^b   Scheper, Rik J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LUNG RESISTANCE PROTEIN; RIBONUCLEOPROTEIN; MONOCLONAL ANTIBODY;

ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CELL FRACTIONATION; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; BIOSYNTHESIS; CELL CULTURE; DRUG RESISTANCE; IMMUNOLOGY; METABOLISM; MOLECULAR WEIGHT; NEOPLASM; UPREGULATION;

ANTIBODIES, MONOCLONAL; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; MOLECULAR WEIGHT; NEOPLASMS; TUMOR CELLS, CULTURED; UP-REGULATION; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 0034651242     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Lehnert, M. Clinical multidrug resistance in cancer: a multifactorial problem. Eur. J. Cancer, 32A: 912-920, 1996.
2. Kedersha, N. L., and Rome, L. H. Isolation and characterization of a novel ribonucleoprotein particle: large structures contain a single species of small RNA. J. Cell Biol., 103: 699-709, 1986.
3. Scheffer, G. L., Wijngaard, P. L. J., Flens, M. J., Izquierdo, M. A., Slovak, M. L., Pinedo, H. M., Meijer, C., Clevers, H. C., and Scheper, R. J. The drug resistance-related protein LRP is the human major vault protein. Nat. Med., 1: 578-582, 1995.
4. Kedersha, N. L., and Rome, L. H. Vaults: large cytoplasmic RNP's that associate with cytoskeletal elements. Mol. Biol. Rep., 14: 121-122, 1990.
5. Kedersham N. L., Miquel, M. C., Bittner, D., and Rome, L. H. Vaults. II. Ribonucleoprotein structures are highly conserved among higher and lower eukaryotes. J. Cell Biol., 110: 895-901, 1990.
6. Kedersha, N. L., Heuser, J. E., Chugani, D. C., and Rome, L. H. Vaults. III. Vault ribonucleoprotein particles open into flower-like structures with octagonal symmetry. J. Cell Biol., 112: 225-235, 1991.
7. Hamill, D. R., and Suprenant, K. A. Characterization of the sea urchin major vault protein-a possible role for vault ribonucleoprotein particles in nucleocytoplasmic transport. Dev. Biol., 190: 117-128, 1997.
8. Rome, L., Kedersha, N., and Chugani, D. Unlocking vaults: organelles in search of a function. Trends Cell Biol., 1: 47-50, 1991.
9. Herrmann, C., Golkaramnay, E., Inman, E., Rome, L., and Volknandt, W. Recombinant major vault protein is targeted to neuritic tips of PC12 cells. J. Cell Biol., 144: 1163-1172, 1999.
10. Abbondanza, C., Rossi, V., Roscigno, A., Gallo, L., Belsito, A., Piluso, G., Medici, N., Nigro, V., Molinari, A. M., Moncharmont, B., and Puca, G. A. Interaction of vault particles with estrogen receptor in the MCF-7 breast cancer cell. J. Cell Biol., 141: 1301-1310, 1998.
11. Kong, L. B., Siva, A. C., Rome, L. H., and Stewart, P. L. Structure of the vault, a ubiquitous cellular component. Structure, 7: 371-379, 1999.
12. Chugani, D. C., Rome, L. H., and Kedersha, N. L. Evidence that vault ribonucleoprotein particles localize to the nuclear pore complex. J. Cell Sci., 106: 23-29, 1993.
13. Scheper, R. J., Broxterman, H. J., Scheffer, G. L., Kaaijk, P., Dalton, W. S., van Heijningen, T. H., van Kalken, C. K., Slovak, M. L., de Vries, E. G., van der Valk, P., Meijer, C. J. L. M., and Pinedo, H. M. Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res., 53: 1475-1479, 1993.
14. Izquierdo, M. A., Shoemaker, R. H., Flens, M. J., Scheffer, G. L., Wu, L., Prather, T. R., and Scheper, R. J. Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines. Int. J. Cancer, 65: 230-237, 1996.
15. Izquierdo, M. A., Scheffer, G. L., Flens, M. J., Giaccone, G., Broxterman, H. J., Meijer, C., van der Valk, P., and Scheper, R. J. Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors. Am. J. Pathol., 148: 877-887, 1996.
16. Izquierdo, M. A., Scheffer, G. L., Schroeijers, A. B., de Jong, M. C., and Scheper, R. J. Vault-related resistance to anticancer drugs determined by the expression of the major vault protein LRP. Cytotechnology, 27: 137-148, 1998.
17. Kitazono, M., Sumizawa, T., Takebayashi, Y., Chen, Z. S., Furukawa, T., Nagayama, S., Tani, A., Takao, S., Aikou, T., and Akiyama, S. Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells. J. Natl. Cancer Inst., 91: 1647-1653, 1999.
18. Flens, M. J., Scheffer, G. L., van der Valk, P., Broxterman, H. J., Eijdems, E., Huysmans, A., Izquierdo, M. A., and Scheper, R. J. Identification of novel drug resistance-associated proteins by a panel of rat monoclonal antibodies. Int. J. Cancer, 73: 249-257, 1997.
19. Kickhoefer, V. A., Rajavel, K. S., Scheffer, G. L., Dalton, W. S., Scheper, R. J., and Rome, L. H. Vaults are up-regulated in multidrug-resistant cancer cell lines. J. Biol. Chem., 273: 8971-8974, 1998.
20. Kickhoefer, V. A., Siva, A. C., Kedersha, N. L., Inman, E. M., Ruland, C., Streuli, M., and Rome, L. H. The 193-kD vault protein, VPARP, is a novel poly(ADP-ribose) polymerase. J. Cell Biol., 146: 917-928, 1999.
21. Kuiper, C. M., Broxterman, H. J., Baas, F., Schuurhuis, G. J., Haisma, H. J., Scheffer, G. L., Lankelma, J., and Pinedo, H. M. Drug transport variants without P-glycoprotein overexpression from a human squamous lung cancer cell line after selection with doxorubicin. J. Cell Pharmacol., 1: 35-41, 1990.
22. Zijlstra, J. G., de Vries, E. G., and Mulder, N. H. Multifactorial drug resistance in an Adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res., 47: 1780-1784, 1987.
23. Taylor, C. W., Dalton, W. S., Parrish, P. R., Gleason, M. C., Bellamy, W. T., Thompson, F. H., Roe, D. J., and Trent, J. M. Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF-7 human breast cancer cell line. Br. J. Cancer, 63: 923-929, 1991.
24. Geysen, H. M., Meloen, R. H., and Barteling, S. J. Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc. Natl. Acad. Sci. USA, 81: 3998-4002, 1984.
25. Slootstra, J. W., Puijk, W. C., Ligtvoet, G. J., Langeveld, J. P., and Meloen, R. H. Structural aspects of antibody-antigen interaction revealed through small random peptide libraries. Mol. Divers., 1: 87-96, 1996.
26. Guan, K. L., and Dixon, J. E. Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase. Anal. Biochem., 192: 262-267, 1991.
27. Peranen, J., Rikkonen, M., and Kaariainen, L. A method for exposing hidden antigenic sites in paraformaldehyde-fixed cultured cells, applied to initially unreactive antibodies. J. Histochem. Cytochem., 41: 447-454, 1993.
28. Bobrow, M. N., Harris, T. D., Shaughnessy, K. J., and Litt, G. J. Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays. J. Immunol. Methods, 125: 279-285, 1989.
29. Bobrow, M. N., Shaughnessy, K. J., and Litt, G. J. Catalyzed reporter deposition, a novel method of signal amplification. II. Application to membrane immunoassays. J. Immunol. Methods, 137: 103-112, 1991.
30. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
31. Laurencot, C. M., Scheffer, G. L., Scheper, R. J., and Shoemaker, R. H. Increased LRP mRNA expression is associated with the MDR phenotype in intrinsically resistant human cancer cell lines. Int. J. Cancer, 72: 1021-1026, 1997.
32. Herrmann, C., Kellner, R., and Volknandt, W. Major vault protein of electric ray is a phosphoprotein. Neurochem. Res., 23: 39-46, 1998.
33. Kickhoefer, V. A., Stephen, A. G., Harritigton, L., Robinson, M. O., and Rome, L. H. Vaults and telomerase share a common subunit, TEP1. J. Biol. Chem., 274: 32712-32717, 1999.